C. Q. Deng

3.3k citations

53 papers · 2.2k indexed · 1 hit paper · h-index 21

Impact in

Neurology top 1%
- Peripheral Neuropathies and Disorders
- Myasthenia Gravis and Thymoma
Cellular and Molecular Neuroscience top 5%
- Hereditary Neurological Disorders

Papers in

Pulmonary and Respiratory Medicine 24
- Pulmonary Hypertension Research and Treatments 20
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 12
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
Neurology 10
- Peripheral Neuropathies and Disorders 10

Co-authors: Vera Bril Marinos C. Dalakas Norman Latov Richard AC Hughes Pieter A. van Doorn Peter D. Donofrio Kim Hanna Ingemar S. J. Merkies
Journals: Pulmonary Circulation (5 papers)Muscle & Nerve (3 papers)European Respiratory Journal (2 papers)The Journal of Heart and Lung Transplantation (2 papers)American Journal of Respiratory and Critical Care Medicine (2 papers)
Partner nations: United States China Germany

In The Last Decade

C. Q. Deng

48 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease 2021 · 336 citations

Peers

Countries citing papers authored by C. Q. Deng

Since Specialization

Citations

This map shows the geographic impact of C. Q. Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Q. Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Q. Deng more than expected).

Fields of papers citing papers by C. Q. Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Q. Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Q. Deng. The network helps show where C. Q. Deng may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Q. Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Q. Deng Line = papers co-authored together C. Q. Deng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Role of Rank in Mismatched Low-Rank Symmetric Matrix Estimation Ping Niu, Mathias Pfau, Arie Setiati, Jie Fan, C. Q. Deng, Zhongyi Huang	2025	1
2	BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension Respiratory Medicine ·Sandeep Sahay, Harold I. Palevsky, Karim El‐Kersh, Ricardo Restrepo‐Jaramillo, Abubakr Bajwa, Blanca Hernandez Bautista, Linda Kašparová, Leslie Spikes, Michael Eggert, Shilpa Johri, Shelley Shapiro, Micah R. Fisher, Trushil Shah, Gautam Ramani, J.P. Mehta, Олена Носань, C. Q. Deng, Peter Smith, Meredith Broderick, Charles D. Burger	2025	0
3	Three-Dimensional Numerical Simulation of the Vortex-Induced Motion Response of Semi-Submersible Platforms Under Wave-Current Coupling Effect Journal of Marine Science and Engineering ·溝上誠司, Wissam Bannouf, C. Q. Deng, Dapeng Zhang	2025	0
4	A systematic review of cheerleading injuries: epidemiological characteristics, biomechanical mechanisms, and prevention strategies Frontiers in Public Health ·C. Q. Deng, Qi Yu	2025	0
5	Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary Fibrosis SHILAP Revista de lepidopterología ·Steven D. Nathan, Jürgen Behr, Vincent Cottin, Lisa Lancaster, Peter Smith, C. Q. Deng, Liebmann, Seong Tae Lim, Leigh Peterson, Kevin R. Flaherty	2024	3
6	Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EV The Journal of Heart and Lung Transplantation ·Raymond L. Benza, Mardi Gomberg‐Maitland, Harrison W. Farber, Carmine Dario Vizza, Meredith Broderick, Louis Holdstock, Andrew C. Nelsen, C. Q. Deng, Mei-siew Lim, R. James White	2022	14
7	Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial American Journal of Respiratory and Critical Care Medicine ·Steven D. Nathan, Victor F. Tapson, Jean Elwing, Franz Rischard, J.P. Mehta, Shelley Shapiro, Eric Shen, C. Q. Deng, Peter Smith, Aaron B. Waxman	2021	44
8	[Low-dose argatroban emerging salvage therapies for heparin-induced thrombocytopenia during artificial liver treatment: a case report]. PubMed ·JeongHyunSeon, Stephania Hokenmaier, C. Q. Deng, Fitri D Mohune, Xiaolin Zhu, Khoiriah Nasution, Bin Wu, Jianzhong Bai, M. B. A. Passos	2021	0
9	A roadmap to using historical controls in clinical trials – by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG) Orphanet Journal of Rare Diseases ·Mercedeh Ghadessi, Rui Tang, Joey Tianyi Zhou, Rong Liu, Chenkun Wang, Kiichiro Toyoizumi, Chaoqun Mei, Lixia Zhang, C. Q. Deng, Robert A. Beckman	2020	99
10	Advance Outcomes - A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in Subjects with Pulmonary Arterial Hypertension Richard N. Channick, Victor F. Tapson, Marc Humbert, C. Q. Deng, Horton Hears, R. Grover, Derek Solum, Vallerie V. McLaughlin	2020	1
11	Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design Journal of Neurology ·C. Q. Deng, Kim Hanna, Vera Bril, Marinos C. Dalakas, Peter D. Donofrio, Pieter A. van Doorn, Hans‐Peter Hartung, Ingemar S. J. Merkies	2011	14
12	PS124. Plasmin (Human) TAL-05-00018 Demonstrates a Good Safety Profile in Patients with Acute Peripheral Arterial Occlusion Journal of Vascular Surgery ·Anthony J. Comerota, David Fineberg, Richard D. Shlansky-Goldberg, C. Q. Deng, Victor J. Marder	2011	1
13	Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study Journal of the Peripheral Nervous System ·Ingemar S. J. Merkies, Richard AC Hughes, Peter D. Donofrio, Vera Bril, Marinos C. Dalakas, Kim Hanna, Hans‐Peter Hartung, Norman Latov, Pieter A. van Doorn, C. Q. Deng, (unknown)	2010	34
14	Exploring the role of CT densitometry: a randomised study of augmentation therapy in α₁-antitrypsin deficiency European Respiratory Journal ·Asger Dirksen, Eeva Piitulainen, David Parr, C. Q. Deng, Marion Wencker, S. B. Shaker, Robert A. Stockley	2009	250
15	Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency Respiratory Research ·David Parr, Asger Dirksen, Eeva Piitulainen, C. Q. Deng, Marion Wencker, Robert A. Stockley	2009	67
16	A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion Journal of Thrombosis and Haemostasis ·Richard D. Shlansky-Goldberg, Akiko Matsumoto, G.A. Baumbach, Jeffrey B. Siegel, Rodney D. Raabe, Timothy P. Murphy, C. Q. Deng, E. Prather Palmer, VJ Marder	2008	26
17	Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial The Lancet Neurology ·Richard AC Hughes, Peter D. Donofrio, Vera Bril, Marinos C. Dalakas, C. Q. Deng, Kim Hanna, Hans‐Peter Hartung, Norman Latov, Ingemar S. J. Merkies, Pieter A. van Doorn	2008	477
18	Evaluation of the clinical efficacy and safety of grapeseed extract in the treatment of fall seasonal allergic rhinitis: a pilot study Annals of Allergy Asthma & Immunology ·David I. Bernstein, 蒋天礼, C. Q. Deng, Karen Murphy, Jonathan A. Bernstein, Rakesh Shukla	2002	33
19	Disability Case Management: Journal of Occupational and Environmental Medicine ·R. Rajendran, 이중환, Rakesh Shukla, M. Alonso-Basante, C. Q. Deng	2000	8
20	Relation of Hemoglobin Measured at Different Times in Pregnancy to Preterm Birth and Low Birth Weight in Shanghai, China American Journal of Epidemiology ·Liming Zhou, Wenwen Yang, Jing Hua, C. Q. Deng, Xin Tao, Rebecca J. Stoltzfus	1998	163

About C. Q. Deng

C. Q. Deng is a scholar working on Pulmonary and Respiratory Medicine, Neurology, Family Practice, Cellular and Molecular Neuroscience and Statistics and Probability, having authored 53 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (20 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Peripheral Neuropathies and Disorders (10 papers), Hereditary Neurological Disorders (8 papers), Peripheral Nerve Disorders (7 papers), Asthma and respiratory diseases (5 papers), Heart Failure Treatment and Management (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). The work is most often cited by research in Neurology (766 citations), Cellular and Molecular Neuroscience (567 citations), Pulmonary and Respiratory Medicine (854 citations), Hematology (196 citations) and Genetics (162 citations). C. Q. Deng has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Vera Bril, Marinos C. Dalakas, Norman Latov, Richard AC Hughes, Pieter A. van Doorn, Peter D. Donofrio, Kim Hanna, Ingemar S. J. Merkies, Hans‐Peter Hartung and David Parr. Their work appears in journals such as Pulmonary Circulation, Muscle & Nerve, European Respiratory Journal, The Journal of Heart and Lung Transplantation and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact